Granules India plans to invest $84 million for expansion: Report

21 Feb 2017 Evaluate

Granules India, one of the leading drug makers in India, is reportedly planning to invest $84 million in setting up new capacities, expanding existing ones and investing in R&D to improve its product mix in favour of higher value-added products. The project cost is proposed to be financed with debt of $68.5 million, including a corporate loan of up to $47.5 million from International Finance Corporation (IFC), and the rest through equity and internal accruals.

Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).

Granules India Share Price

559.50 -17.30 (-3.00%)
09-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.60
Dr. Reddys Lab 1286.40
Cipla 1325.15
Zydus Lifesciences 908.65
Lupin 2301.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×